Quris Competitors and Similar CompaniesClear all
Quris's competitors and similar companies include Nucleai, ZielBio and Salgomed.
 Quris Quris Technologies is a biotechnology company that provides a platform for clinical prediction. |  Nucleai Nucleai is a company that develops an AI-powered spatial biology platform for drug development and clinical treatment. |  ZielBio ZielBio is a biotechnology company that identifies novel disease targets and develops therapeutic interventions to improve patient outcomes. |  Salgomed Salgomed is a company that offers a platform for precision medicine that can be used to identify cancer drug targets and provide the clinical validation of candidate drugs. | |
Founding Date | Founding Date 2020 | Founding Date 2018 | Founding Date 2012 | Founding Date 2012 |
Type | Type Private | Type Private | Type Private | Type Private |
Tags | ||||
Locations | Locations Tel Aviv-Yafo, IL HQ Boston, US | Locations Chicago, US HQ Tel Aviv, IL Chicago, US | Locations Charlottesville, US HQ | Locations HQ |
Employees | Employees 55 | Employees 845% decrease | Employees 10 | Employees 5 |
Funding | ||||
Latest funding round | Latest funding round $ 19m (over 4 years ago) | Latest funding round $ 33m (about 4 years ago) | Latest funding round $ 25.1m (over 6 years ago) | Latest funding round $ 205k (almost 14 years ago) |
Total funding raised | Total funding raised $ 28m | Total funding raised $ 46.5m | Total funding raised $ 25.1m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Nucleai
HQ
Chicago, US
Employees
84↓ 5% decrease
Nucleai is a company that develops an AI-powered spatial biology platform for drug development and clinical treatment.
View companyZielBio
HQ
Charlottesville, US
Employees
10
ZielBio is a biotechnology company that identifies novel disease targets and develops therapeutic interventions to improve patient outcomes.
View companySalgomed
HQ
Employees
5
Salgomed is a company that offers a platform for precision medicine that can be used to identify cancer drug targets and provide the clinical validation of candidate drugs.
View company